RxDoctor Payments Data

Jason Nemitz, MD

Foot and Ankle Surgery · Fort Myers, FLNPI 1871703488

Payments from drug & device makers

$4,185in general payments, 2019–2025

Across 78 payments — averaging $53.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$4K
  • Bioventus LLC$126
  • Vertex$120
  • Baxter Healthcare$85
  • Next Science LLC$71
  • Organogenesis Inc.$35
  • plus $129 from 6 others

What the payments were for

  • Travel & lodging$2446%
  • Food & beverage$3,85692%
  • Other$852%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Stryker63$3,619
Bioventus LLC5$126
Vertex1$120
Baxter Healthcare1$85
Next Science LLC1$71
Organogenesis Inc.1$35
Zimmer Biomet1$34
Heron Therapeutics, Inc.1$24
Coastal Medical Technologies LLC1$23
Radius Health, Inc.1$18
Orthogenrx Inc.1$17
Amgen1$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,185 in reported general payments places this provider in the 55th percentile of 850 foot and ankle surgery providers in Florida.

See all foot and ankle surgery providers in Florida

Medicare billing

Part B allowed, 2024
$284,169
Medicare patients
561
Services billed
3,705

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Meloxicam380$1,053
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen96$985
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen38$415
Cephalexin21$362
Gabapentin40$259
Tramadol Hcl95$178
Methylprednisolone13$127

Paid to pharmacies, not to this prescriber.

Other foot and ankle surgery in Fort Myers

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →